A study supported the ellipsoid zone loss as a meaningful biomarker that can be used to guide clinical trial design in ...
Joel S. Schuman, MD, FACS, highlights home tonometry, virtual visual fields, and portable OCT devices as promising tools, ...
Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback